Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen and the University of Texas Share Funding for Biodefense Proteomics Tool

NEW YORK, Sept. 3 (GenomeWeb News) -- Ciphergen Biosystems of Fremont, Calif., and the University of Texas Medical Branch-Galveston today announced funding from the National Institutes of Health to develop new strategies for the early diagnosis of viral infections caused by exposure to bioterrorism agents.

 

The amount of the funding was not disclosed.

 

The funding was based on data submitted from a prototype thioaptamer array, which combines UTMB's proprietary technology with Ciphergen's SELDI protein chip technology. The collaborators will atempt to identify and characterize novel protein interactions associated with viral infection in response to pathogens.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.